TMEM44 and gastric cancer: Taking advantage of this regulatory mechanism, we generated chitosan‐gelatin‐epigallocatechin gallate (CGE) nanoparticles and used them to deliver siRNA targeting TMEM44‐AS1 (si‐TMEM44‐AS1) aiming to reverse 5‐FU resistance in GC.